References
- Alaiya AA, Franzen B, Hagman A, Dysvik B, Roblick UJ, Becker S, et al. Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer 2002; 98: 895–9
- Auranen A, Grenman S, Mäkinen J, Pukkala E, Sankila R, Salmi T. Borderline ovarian tumors in Finland: epidemiology and familial occurrence. Am J Epidemiol 1996; 144: 548–53
- Camatte S, Morice P, Atallah D, Pautier P, Lhommé C, Haie-meder C, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg 2002; 195: 332–8
- Darai E, Teboul J, Fauconnier A, Scoazed J-Y, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998; 77: 451–7
- Trimble EL, Trimble CL. Epithelial ovarian tumors of low malignant potential. Cancer of the Ovary, M Markman, WJ Hoskins. Raven Press Ltd, New York 1993; 415–28
- Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. Cancer: principles & practice oncology, 4th edn, VT DeVita, Jr, S Hellman, SA Rosenberg. J.B. Lippincott Co, Philadelphia 1993; 1226–63
- Bjorge T, Engeland A, Hansen S, Trope CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663–70
- Heintz APM, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. Int J Gynaecol Obstet 2006; 95(Suppl 1)S161–92
- Burger CW, Prinssen HM, Baak JPA, Wagenaar N, Kenemans P. The management of borderline epithelial tumors of the ovary. Int J Gynecol Cancer 2000; 10: 181–97
- Prat J, Nictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002; 26: 1111–28
- Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, et al. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer 2004; 100: 1045–52
- FIGO staging classifications and clinical practice guidelines in management of gynecologic cancers. Int J Gynaecol Obstet 2000; 70: 209–62.
- Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lécuru F. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gyn Oncol 2005; 98: 390–5
- Gershenson DM. Contemporary treatment of borderline ovarian tumors. Cancer Invest 1999; 17: 206–10
- Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 2004; 100: 1145–51
- Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999; 85: 905–11
- Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001; 19: 2658–64
- Kumpulainen S, Kuoppala T, Leminen A, Penttinen J, Puistola U, Pukkala E, et al. Surgical treatment of ovarian cancer in different hospital categories – a prospective nation-wide study in Finland. Eur J Cancer 2006; 42: 388–95
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42
- Dickman, PW, Voutilanen, ET, Hakulinen, T. SURV3: relative survival analysis program, version 3.01, Helsinki, Finnish Cancer Registry, 2002
- Winter WE III, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002; 100: 671–6
- Gilks CB, Alkushi A, Yue JJ, Lanvin D, Ehlen TG, Miller DM. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2003; 22: 25–8
- Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhommé C, et al. Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004; 40: 1842–9
- Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol 2005; 24: 4–25
- Boriboonhirunsarn D, Sernboon A. Accuracy of frozen section in the diagnosis of malignant ovarian tumor. J Obstet Gynaecol Res 2004; 30(5)394–9
- Pinto PB, Andrade LA, Derchain SF. Accuracy of intraoperative frozen section diagnosis of ovarian tumors. Gynecol Oncol 2001; 81: 230–1
- Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol 2000; 19: 69–75
- Chambers JT, Merino MJ, Kohorn EI, Schwartz PE. Borderline ovarian tumors. Am J Obstet Gynecol 1988; 159: 1088–94
- Rao GG, Skinner EN, Gehrig PA, Duska LR, Miller DS, Schorge JO. Fertility-sparing surgery for ovarian low malignant potential tumors. Gyn Oncol 2005; 98: 263–6
- Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary. Cancer 1998; 82: 141–6
- Tingulstad S, Tingulstad S, Hagen B, Skjeldestad FE, Onsrud M, Kiserud T, et al. Evaluation of a risk of malignancy index based on serum CA 125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol 1996; 103: 826–31